US Patent Issued to Case Western Reserve University, The United States Government as Represented by The Department of Veteran Affairs, The Cleveland Clinic Foundation, UH Cleveland Medical Center on March 17 for "Radiomic heterogeneity as prognostic predictor for treatment with CDK 4/6 inhibitors in hormone receptor-positive metastatic breast cancer" (Ohio, Pennsylvania Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,338, issued on March 17, was assigned to Case Western Reserve University (Cleveland), The United States Government as Represented by The Department of Veteran Affairs (Washington), The Cleveland Clinic Foundation (Cleveland) and UH Cleveland Medical Center (Cleveland).

"Radiomic heterogeneity as prognostic predictor for treatment with CDK 4/6 inhibitors in hormone receptor-positive metastatic breast cancer" was invented by Anant Madabhushi (Shaker Heights, Ohio), Nathaniel Braman (Bethel Park, Pa.), Siddharth Kunte (Toledo, Ohio) and Alberto Montero (Cleveland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method...